Shanghai Allist Pharmaceuticals (688578.SS) Earnings Analysis
Shanghai Allist Pharmaceuticals (688578.SS) next reports earnings on 2026-08-20. Trailing P/E 23.28.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 688578.SS next report earnings?
| Next earnings date | 2026-08-20 |
|---|---|
| Consensus EPS estimate | n/a |
| Revenue estimate | n/a |
688578.SS earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-04-22 | 1.41 CNY | n/a | n/a | n/a |
| 2026-02-27 | 1.26 CNY | n/a | n/a | n/a |
| 2025-08-27 | 1.42 CNY | n/a | n/a | n/a |
| 2024-10-24 | 0.904 CNY | n/a | n/a | n/a |
| 2024-08-20 | 0.778 CNY | n/a | n/a | n/a |
688578.SS valuation and analyst view
| Trailing P/E | 23.28 |
|---|---|
| Trailing EPS | 5.366 CNY |
| Price / book | 7.24 |
| Dividend yield | 0.80% |
| Market cap | 59.05B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Shanghai Allist Pharmaceuticals (688578.SS)'s next earnings date?
Shanghai Allist Pharmaceuticals is next scheduled to report on 2026-08-20.
Did 688578.SS beat earnings last quarter?
Consensus estimate data was not available for 688578.SS's 2026-04-22 report.
What is 688578.SS's current P/E ratio and EPS?
688578.SS trades at a trailing P/E of 23.28 on trailing EPS of 5.365888371111111 CNY.
What do analysts rate 688578.SS?
688578.SS has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.